Aurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers

Aurora Cannabis Inc. (“Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC |…

Aurora Cannabis Inc. (“Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC | CTTH) announced today the successful commercialization of CTT’s cannabinoid-infused sublingual wafers. The new cannabis product line, a first of its kind, has been launched by Aurora in the Canadian medical […]

The post Aurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *